BIOA ALERT: Rosen Law Firm Reminds BioAmber Inc. Investors of Important Deadline in First Filed Class Action - BIOA
20. April 2017 12:27 ET
|
The Rosen Law Firm PA
NEW YORK, April 20, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of BioAmber Inc. securities (NYSE:BIOA): (1) pursuant and/or traceable to...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against BioAmber Inc. - BIOA
06. April 2017 13:23 ET
|
The Rosen Law Firm PA
NEW YORK, April 06, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of BioAmber Inc. securities...
Synthetic Biology Market Growing With Rise In Medical Demand - IndustryARC
17. März 2017 13:30 ET
|
IndustryARC
Hyderabad, India, March 17, 2017 (GLOBE NEWSWIRE) -- The report “Synthetic Biology Market: By Tool (XNAS, Chassis Organisms) By Technology (Bioinformatics, DNA sequencing, integrated systems) By...